Science & Technology Review
|
2023, 41(15): 79-88
• Reviews •
Research progress of photobiomodulation for Alzheimer's disease
Full
XU Guodong1, LV Zeping2,3*, WANG Daifa4*, GUO Rong4*
Affiliations
1. Department of Infectious Disease, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang 212300, China
2. Rehabilitation Hospital Affiliated to National Research Center for Rehabilitation Assistive Devices, Beijing 100176, China
3. Beijing Key Laboratory of Assistive Technology for Rehabilitation of Elderly Dysfunction, Beijing 100176, China
4. School of Biological Science and Medical Engineering, Beihang University, Beijing 100083, China
Published: 2023-08-13
doi: 10.3981/j.issn.1000-7857.2023.15.008
Outline
Alzheimer's disease (AD) is a neurodegenerative disease with progressive memory loss and cognitive impairment. Photobiomodulation (PBM) is a promising and innovative therapy for AD treatment. This article reviews the mechanisms of action of PBM for AD treatment and related animal experiments and clinical studies, then analyzes the feasibility, effectiveness, research priorities and challenges of PBM for AD treatment, and finally summarizes the future research trends of PBM for AD treatment, so as to provide a reference for follow-up research.
Alzheimer's disease
/
photobiomodulation
/
non-invasive treatment
XU Guodong, LV Zeping, WANG Daifa, GUO Rong.
Research progress of photobiomodulation for Alzheimer's disease[J].
Science & Technology Review,
2023
, 41
(15)
: 79
-88
.
DOI: 10.3981/j.issn.1000-7857.2023.15.008
Year 2023 volume 41 Issue 15
PDF
914
426
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2023.15.008
- Receive Date:2022-08-18
- Online Date:2023-08-30
- Published:2023-08-13